Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
57 Leser
Artikel bewerten:
(0)

Contraceptives - Global Strategic Business Report 2015-2022 - Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion - Research and Markets

DUBLIN, Feb. 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Contraceptives - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Contraceptives in US$ by the following Contraception Methods: Hormonal Contraceptives (Oral Contraceptives, & Other Hormonal Contraceptives), and Condoms.

Companies Mentioned

  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Allergan plc
  • Ansell Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Fuji Latex Co. Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Karex Berhad
  • Lupin Pharmaceuticals Inc.
  • Mankind Pharma Ltd.
  • Merck Sharp & Dohme Corp.
  • Mayer Laboratories, Inc.
  • Okamoto Industries, Inc.
  • Pfizer, Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc.
  • Sagami Rubber Industries Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thai Nippon Rubber Industry Co., Ltd.
  • The Female Health Company/Veru Healthcare

Key Topics Covered:

1. INDUSTRY OVERVIEW

2. COMPETITION

  • Bayer's Oral Contraceptive Pills: In the Midst of Controversies
  • Bayer's Yasmin: A Resounding Brand Success Worldwide when Launched
  • Innovative Promotion Strategies Enhance Product Appeal
  • Aging Population Adds to Manufacturer Concerns
  • Manufacturers Capitalize on the Healthcare-Related Role of Contraceptives
  • Teen Population: A Lucrative Demographic Segment and the New Advertising Target
  • Supermarkets and Internet Gain Importance in Contraceptives Retail


3. MARKET TRENDS, ISSUES & DRIVERS

  • Study Reveals Positive Effects of Contraceptives on HIV- Infected Women
  • Contraceptive Innovations and Advancements: Spearheading Growth
  • Major Condom Innovations
  • S.T.EYE: A Condom that Changes Color in the Presence of an STI
  • A Super Condom with the Potential to Eradicate HIV
  • Other Recent Innovations in Condoms
  • Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion
  • Despite Waning Popularity, Oral Contraceptives Continue to Sustain Market Domination
  • Research Findings In Favor of and Against the Pill
  • Considerably Lowers Death Rate from Ovarian Cancer
  • Helps Reduce Risk of Endometrial Cancer
  • Increases Risk of Ischemic Stroke
  • Heightens the Risk of Crohn's Disease

4. TRADE STATISTICS

5. PRODUCT OVERVIEW

6. PRODUCT LAUNCHES & APPROVALS

7. RECENT INDUSTRY ACTIVITY

8. FOCUS ON SELECT GLOBAL PLAYERS

9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 92 (including Divisions/Subsidiaries 104)

- The United States (25)
- Canada (1)
- Japan (3)
- Europe (24)

- France (3)
- Germany (6)
- The United Kingdom (5)
- Italy (1)
- Rest of Europe (9)

- Asia-Pacific (Excluding Japan) (43)
- Latin America (6)
- Africa (2)

For more information about this report visit http://www.researchandmarkets.com/research/w57pl4/contraceptives

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.